Clinical Trials Logo

Brain Injury clinical trials

View clinical trials related to Brain Injury.

Filter by:

NCT ID: NCT00724594 Completed - Brain Injury Clinical Trials

Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio)

Start date: August 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this trial was to find the best dose of N-acetylcysteine (NAC) to decrease brain injury in babies exposed to intrauterine infection without causing significant side effects.

NCT ID: NCT00715494 Completed - Muscle Weakness Clinical Trials

A Pilot Study of Rehabilitation Among Intensive Care Unit (ICU) Survivors: the RETURN Trial

RETURN
Start date: July 2008
Phase: N/A
Study type: Interventional

Intensive care unit (ICU) hospitalization saves lives but often does so at a high personal cost to ICU survivors who frequently experience significant cognitive impairment and an array of physical and functional disabilities that limit their recovery and quality of life. While the problems experienced by these patients are likely amenable to rehabilitation, few ICU survivors receive focused rehabilitation following hospital discharge. The purpose of this study is to initiate and test the feasibility of a complex intervention incorporating a cognitive, physical, and functional rehabilitation program at the time of hospital discharge and implement this 12 week program using in-home visits and tele-technology. We hypothesize that this interdisciplinary rehabilitation program, initiated at hospital discharge and implemented using in-home visits and tele-technology, will result in improved recovery of neuropsychological and physical performance and overall functional status.

NCT ID: NCT00649961 Completed - Premature Birth Clinical Trials

Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study

MIND
Start date: May 2010
Phase: Phase 2
Study type: Interventional

Preterm babies are at risk of brain injury. Melatonin, a naturally occurring hormone, may reduce this risk. The unborn baby receives melatonin from the mother but following premature delivery there maybe a period of prolonged melatonin deficiency. This deficiency may be harmful because studies suggest that melatonin is important in protecting the brain and reducing the risk of brain injury after preterm birth. The purpose of this study is to find the ideal dose of melatonin to give to preterm babies. We intend to study a total of 24 babies less than 31 weeks gestation and who are less than 7 days old.

NCT ID: NCT00618085 Completed - Stroke Clinical Trials

Motor Imagery Practice in Neurological Rehabilitation

Start date: February 2008
Phase: Phase 2
Study type: Interventional

Motor imagery is a technique widely used in learning skills. Its effectiveness has been proven in various sports and in musicians. A recent review (Braun et al. 2006) suggested that this technique may also be effective in rehabilitation of patients with neurological disease or damage, but that further research was needed. The main purpose of this research is to discover whether motor imagery practice is beneficial in the rehabilitation of skills in patients who have some disability due to neurological disease or damage. The principal research question is: are physiotherapy and occupational therapy given incorporating motor imagery more effective than standard care (i.e., the same therapies but without integrated motor imagery) in re-training task specific performance for patients with neurological disease or damage?

NCT ID: NCT00596765 Completed - Brain Injury Clinical Trials

Neuropsychological Cognitive Behavioral Therapy for Patients With Acquired Brain Injury

Start date: September 2007
Phase: N/A
Study type: Interventional

Acquired brain injury can result in impaired everyday functioning as well as psychosocial problems, including depressive symptoms, irritability, or negative self-concept. The purpose of this study is to determine whether a combination of neuropsychological and cognitive behavioral therapy is effective in the treatment of these sequelae.

NCT ID: NCT00571623 Completed - Brain Injury Clinical Trials

Automated Chest Physiotherapy to Improve Outcomes in Neuro

ACTION-ICP
Start date: September 2007
Phase: N/A
Study type: Observational

Following current standard-of-care, subjects data (brain pressure) will be recorded for 1 hour and include 10-minutes of data during which the subject recieves chest physiotherapy (CPT). The hypothesis is that CPT is not harmful to brain pressure.

NCT ID: NCT00571441 Completed - Ischemic Stroke Clinical Trials

Estimating Volume Using LiDCO

EVOLVE
Start date: December 2007
Phase: N/A
Study type: Observational

We hypothesize that the stroke volume variation measured using the commercially available LiDCO monitor provides a reasonable estimate of volume when compared to standard measures. This study will collate data that is already being collected by the bedside nurses.

NCT ID: NCT00538616 Completed - Brain Injury Clinical Trials

Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion

PrePARE
Start date: January 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate brain injury when two different drugs (propofol and precedex) are used to sedate patients who need a neurologic exam.

NCT ID: NCT00462683 Completed - Stroke Clinical Trials

Bone Loss, Fractures, and Management of Bone Health in People With Stroke in Managed Rehabilitation Settings

Start date: July 2007
Phase: N/A
Study type: Observational

The purpose of the study is to evaluate the state of bone health of brain injury patients being seen within a rehabilitation setting. Osteopenia is a condition of bone in which decreased calcification, decreased density, or reduced mass occurs. Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly. More specifically, the prevalence of osteopenia and osteoporosis at specific anatomic locations (e.g., forearms, hips, spine) will be determined as will specific interventions (e.g., use of vitamins, nutritional supplements, specific prescription medications) that people with brain injury may be applying, or have applied, to manage their bone health. An attempt will also be made to evaluate severity of brain injury, based on loss of muscle strength/function, and to compare this data with bone-focused information such as bone mineral density (BMD), falls, and history.

NCT ID: NCT00453921 Completed - Brain Injury Clinical Trials

Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI)

Start date: February 2007
Phase: N/A
Study type: Interventional

Traumatic brain injury (TBI) is a significant public health problem, with 1.5-2.0 million Americans injured each year. Cognitive deficits, particularly in the domains of memory and attention are frequently the source of lingering disability after TBI and a source of enormous distress to the injured individuals and their family/caregivers. To date, interventions to ameliorate chronic cognitive deficits have been directed at either pharmacological interventions or cognitive rehabilitation. We propose to (1) To compare the efficacy of three interventions: memory and attention training (MAAT), methylphenidate, and memory/attention training in combination with methylphenidate and (2) use functional MRI (fMRI) to characterize changes in activation of the neural circuitry of memory and attention due to MAAT alone, methylphenidate alone, and MAAT in combination with methylphenidate. This is a two by two design with medication (methylphenidate/placebo) and cognitive therapy (Memory and Attention Training (MAAT) or an Attention control intervention) as possible interventions. Using a randomized, placebo-controlled, double-blind design, 200 individuals with persistent cognitive deficits 6-12 months after MTBI will be randomized to receive a six week trial of either (1) MAAT and placebo, (2) MAAT and methylphenidate (0.3 mg/kg BID), (3) attention control intervention and methylphenidate (0.3 mg/kg BID), or (4) attention control intervention and placebo. Symptom distress, attention and memory performance, and activation patterns of the neural circuitry of attention and memory while undergoing fMRI will be characterized at baseline, and after the four treatment conditions. This study will provide important information on three interventions for the most disabling sequelae of an enormous public health problem. Further, it will help to clarify underlying neural mechanisms and suggest additional treatment possibilities.